Kwality Pharmaceuticals Share Price

CMP as on21-Oct-20 12:17

₹ 59.00
-0.8 -1.34%


₹ 59.00

Turnover (lac)

₹ 1

Prev. Close

₹ 59.80

Day's Vol (shares)

₹ 3,000

Day's Range

₹ 59.00
₹ 59.00

Corporate Action

Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 22-Jun-2020 - -
Kwality Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/06/2020 ,inter alia, to consider and approve Pursuant to regulation 29 of the SEBI (Listing obligations and disclosure requirements) Regulations, 2015, we hereby inform the stock exchange that the meeting of board of directors of the company is scheduled to be held on Tuesday, June 30, 2020 at 5:00 p.m. at VILLAGE NAGKALAN, MAJITHA ROAD, AMRITSAR to consider and approve the standalone & consolidated audited financial results for the half year and financial year ended on 31st March, 2020. Further, as per our earlier communication vide our letter dated 31st March 2020 and in accordance with the Companys Code of Conduct for Prohibition of Insider Trading framed pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, the Trading window for dealing in securities of the company for all the Board of Directors, Designated Persons and their immediate relatives will remain closed till 48 hours after the financial results of the company are made public on June 30, 2020. Audited Results (Revised) (As Per BSE Bulletin Dated on 30-06-2020)
Board Meeting - 06-Nov-2019 - -
Kwality Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2019 ,inter alia, to consider and approve 1) To consider the Standalone and Consolidated Unaudited Financial Results of the Company for the half year ended on 30th September, 2019. 2) To consider any other matter with the permission of the Chair. With respect to captioned subject, we wish to inform you that the Board of Directors in its Meeting held today has inter-alia, considered and approved the standalone and consolidated Un-Audited Financial Results for the half-year ended September 30, 2019. We are submitting herewith the standalone and consolidated un-audited financial results under Regulation 33 of the Securities and Exchange board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the half year ended as on 30.09.2019 along with the limited review reports thereon. (As Per BSE Announcement dated on 14/11/2019)